hexamethonium has been researched along with Pheochromocytoma, Extra-Adrenal in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Effects of hirsutine, an alkaloid that produces a potent ganglion blocking effect, were investigated using rat pheochromocytoma PC12 cells." | 7.68 | Inhibition of ion channels by hirsutine in rat pheochromocytoma cells. ( Fujimori, K; Harada, M; Inoue, K; Nakazawa, K; Ohara-Imaizumi, M; Ozaki, Y; Takanaka, A; Watano, T, 1991) |
| "Effects of hirsutine, an alkaloid that produces a potent ganglion blocking effect, were investigated using rat pheochromocytoma PC12 cells." | 3.68 | Inhibition of ion channels by hirsutine in rat pheochromocytoma cells. ( Fujimori, K; Harada, M; Inoue, K; Nakazawa, K; Ohara-Imaizumi, M; Ozaki, Y; Takanaka, A; Watano, T, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakazawa, K | 1 |
| Watano, T | 1 |
| Ohara-Imaizumi, M | 1 |
| Inoue, K | 1 |
| Fujimori, K | 1 |
| Ozaki, Y | 1 |
| Harada, M | 1 |
| Takanaka, A | 1 |
1 other study available for hexamethonium and Pheochromocytoma, Extra-Adrenal
| Article | Year |
|---|---|
Inhibition of ion channels by hirsutine in rat pheochromocytoma cells.
Topics: Adrenal Gland Neoplasms; Alkaloids; Animals; Calcium Channels; Dopamine; Electrophysiology; Ganglion | 1991 |